List of Tables
Table 1. Dendritic Cell Cancer Vaccines Market Trends
Table 2. Dendritic Cell Cancer Vaccines Market Drivers & Opportunity
Table 3. Dendritic Cell Cancer Vaccines Market Challenges
Table 4. Dendritic Cell Cancer Vaccines Market Restraints
Table 5. Global Dendritic Cell Cancer Vaccines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Dendritic Cell Cancer Vaccines Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Dendritic Cell Cancer Vaccines Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Dendritic Cell Cancer Vaccines Product Type
Table 9. Key Companies Time to Begin Mass Production of Dendritic Cell Cancer Vaccines
Table 10. Global Dendritic Cell Cancer Vaccines Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dendritic Cell Cancer Vaccines as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Dendritic Cell Cancer Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Dendritic Cell Cancer Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Dendritic Cell Cancer Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Dendritic Cell Cancer Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Dendritic Cell Cancer Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Dendritic Cell Cancer Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Dendritic Cell Cancer Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Dendritic Cell Cancer Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Dendritic Cell Cancer Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Dendritic Cell Cancer Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Dendritic Cell Cancer Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Dendritic Cell Cancer Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Dendritic Cell Cancer Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Dendritic Cell Cancer Vaccines Sales Value by Region (2019-2024) & (%)
Table 27. Global Dendritic Cell Cancer Vaccines Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Dendritic Cell Cancer Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Dendritic Cell Cancer Vaccines Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Dendritic Cell Cancer Vaccines Sales Value, (2025-2030) & (US$ Million)
Table 31. 3M Company Basic Information List
Table 32. 3M Company Description and Business Overview
Table 33. 3M Company Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 34. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of 3M Company (2019-2024)
Table 35. 3M Company Recent Developments
Table 36. Activarti Basic Information List
Table 37. Activarti Description and Business Overview
Table 38. Activarti Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 39. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Activarti (2019-2024)
Table 40. Activarti Recent Developments
Table 41. Argos Therapeutics Basic Information List
Table 42. Argos Therapeutics Description and Business Overview
Table 43. Argos Therapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 44. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Argos Therapeutics (2019-2024)
Table 45. Argos Therapeutics Recent Developments
Table 46. Batavia Bioservices Basic Information List
Table 47. Batavia Bioservices Description and Business Overview
Table 48. Batavia Bioservices Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 49. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Batavia Bioservices (2019-2024)
Table 50. Batavia Bioservices Recent Developments
Table 51. Bellicum Pharmaceuticals Basic Information List
Table 52. Bellicum Pharmaceuticals Description and Business Overview
Table 53. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 54. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Bellicum Pharmaceuticals (2019-2024)
Table 55. Bellicum Pharmaceuticals Recent Developments
Table 56. Creagene Basic Information List
Table 57. Creagene Description and Business Overview
Table 58. Creagene Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 59. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Creagene (2019-2024)
Table 60. Creagene Recent Developments
Table 61. DanDrit Biotech Basic Information List
Table 62. DanDrit Biotech Description and Business Overview
Table 63. DanDrit Biotech Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 64. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of DanDrit Biotech (2019-2024)
Table 65. DanDrit Biotech Recent Developments
Table 66. DCPrime Basic Information List
Table 67. DCPrime Description and Business Overview
Table 68. DCPrime Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 69. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of DCPrime (2019-2024)
Table 70. DCPrime Recent Developments
Table 71. Sanpower Corporation Basic Information List
Table 72. Sanpower Corporation Description and Business Overview
Table 73. Sanpower Corporation Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 74. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Sanpower Corporation (2019-2024)
Table 75. Sanpower Corporation Recent Developments
Table 76. Elios Therapeutics Basic Information List
Table 77. Elios Therapeutics Description and Business Overview
Table 78. Elios Therapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 79. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Elios Therapeutics (2019-2024)
Table 80. Elios Therapeutics Recent Developments
Table 81. ImmunoCellular Therapeutics Basic Information List
Table 82. ImmunoCellular Therapeutics Description and Business Overview
Table 83. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 84. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of ImmunoCellular Therapeutics (2019-2024)
Table 85. ImmunoCellular Therapeutics Recent Developments
Table 86. Immunicum Basic Information List
Table 87. Immunicum Description and Business Overview
Table 88. Immunicum Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 89. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Immunicum (2019-2024)
Table 90. Immunicum Recent Developments
Table 91. Kiromic Basic Information List
Table 92. Kiromic Description and Business Overview
Table 93. Kiromic Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 94. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Kiromic (2019-2024)
Table 95. Kiromic Recent Developments
Table 96. Medigene Basic Information List
Table 97. Medigene Description and Business Overview
Table 98. Medigene Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 99. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Medigene (2019-2024)
Table 100. Medigene Recent Developments
Table 101. Merck Basic Information List
Table 102. Merck Description and Business Overview
Table 103. Merck Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 104. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Merck (2019-2024)
Table 105. Merck Recent Developments
Table 106. Northwest Biotherapeutics Basic Information List
Table 107. Northwest Biotherapeutics Description and Business Overview
Table 108. Northwest Biotherapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 109. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Northwest Biotherapeutics (2019-2024)
Table 110. Northwest Biotherapeutics Recent Developments
Table 111. Glaxo Smith Kline Basic Information List
Table 112. Glaxo Smith Kline Description and Business Overview
Table 113. Glaxo Smith Kline Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 114. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Glaxo Smith Kline (2019-2024)
Table 115. Glaxo Smith Kline Recent Developments
Table 116. Tellaorporation Basic Information List
Table 117. Tellaorporation Description and Business Overview
Table 118. Tellaorporation Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 119. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Tellaorporation (2019-2024)
Table 120. Tellaorporation Recent Developments
Table 121. Vaxil BioTherapeutics Basic Information List
Table 122. Vaxil BioTherapeutics Description and Business Overview
Table 123. Vaxil BioTherapeutics Dendritic Cell Cancer Vaccines Products, Services and Solutions
Table 124. Revenue (US$ Million) in Dendritic Cell Cancer Vaccines Business of Vaxil BioTherapeutics (2019-2024)
Table 125. Vaxil BioTherapeutics Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Dendritic Cell Cancer Vaccines Downstream Customers
Table 129. Dendritic Cell Cancer Vaccines Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Dendritic Cell Cancer Vaccines Product Picture
Figure 2. Global Dendritic Cell Cancer Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Dendritic Cell Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. Dendritic Cell Cancer Vaccines Report Years Considered
Figure 5. Global Dendritic Cell Cancer Vaccines Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Dendritic Cell Cancer Vaccines Revenue in 2023
Figure 7. Dendritic Cell Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. CreaVax Picture
Figure 9. Sipuleucel-T (Provenge) Picture
Figure 10. Others Picture
Figure 11. Global Dendritic Cell Cancer Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Dendritic Cell Cancer Vaccines Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Pediatrics
Figure 14. Product Picture of Adults
Figure 15. Global Dendritic Cell Cancer Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Dendritic Cell Cancer Vaccines Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Dendritic Cell Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Dendritic Cell Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Dendritic Cell Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Dendritic Cell Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Dendritic Cell Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Dendritic Cell Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Dendritic Cell Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Dendritic Cell Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Dendritic Cell Cancer Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Dendritic Cell Cancer Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Dendritic Cell Cancer Vaccines Sales Value (%), (2019-2030)
Figure 28. United States Dendritic Cell Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Dendritic Cell Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Dendritic Cell Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Dendritic Cell Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Dendritic Cell Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Dendritic Cell Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 34. China Dendritic Cell Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Dendritic Cell Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 36. China Dendritic Cell Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Dendritic Cell Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Dendritic Cell Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Dendritic Cell Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Dendritic Cell Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Dendritic Cell Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Dendritic Cell Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Dendritic Cell Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Dendritic Cell Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Dendritic Cell Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 46. India Dendritic Cell Cancer Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Dendritic Cell Cancer Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 48. India Dendritic Cell Cancer Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 49. Dendritic Cell Cancer Vaccines Industrial Chain
Figure 50. Dendritic Cell Cancer Vaccines Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
